Haemodynamic effects of acute and chronic administration of low dose carvedilol, a vasodilating beta-blocker in patients with cirrhosis and portal hypertension

被引：0
|
作者：
Tripathi, D [1 ]
Therapondos, G [1 ]
Lui, HF [1 ]
Stanley, AJ [1 ]
Hayes, PC [1 ]
机构：
[1] Royal Infirm, Dept Med, Liver Unit, Edinburgh, Midlothian, Scotland
来源：
GUT | 2001年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
392
引用
收藏
页码：A104 / A104
页数：1
相关论文
共 50 条
  • [31] COMPARISON OF A NEW VASODILATING BETA-BLOCKER, CARVEDILOL, WITH ATENOLOL IN THE TREATMENT OF MILD-TO-MODERATE ESSENTIAL-HYPERTENSION (VOL 7, PG 135, 1994)
    RUILOPE, LM
    AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (04) : 379 - 379
  • [32] Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension
    Sekiyama, T
    Komeichi, H
    Nagano, T
    Ohsuga, M
    Terada, H
    Katsuta, Y
    Satomura, K
    Aramaki, T
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1997, 47 (04): : 353 - 355
  • [33] RENAL EFFECTS OF PINACIDIL IN HYPERTENSIVE PATIENTS ON CHRONIC BETA-BLOCKER THERAPY
    KRUSELL, LR
    CHRISTENSEN, CK
    PEDERSEN, OL
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (06) : 641 - 647
  • [34] OPPOSING ACUTE AND CHRONIC BEHAVIORAL-EFFECTS OF A BETA-BLOCKER, PROPRANOLOL, IN THE RAT
    SALMON, P
    GRAY, JA
    PSYCHOPHARMACOLOGY, 1985, 86 (04) : 480 - 486
  • [35] Beta-blocker dose does not influence the beneficial effects of carvedilol compared to metoprolol in the patients with heart failure: Results from the Carvedilol or Metoprolol European Trial (COMET)
    Metra, M
    Poole-Wilson, PA
    Cleland, JG
    Di Lenarda, A
    Hanrath, P
    Komajda, M
    Lubsen, J
    Lutiger, B
    Remme, WJ
    Scherhag, A
    Charlesworth, A
    Torp-Pedersen, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 206A - 206A
  • [36] Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension
    Predel, HG
    Mainka, W
    Schillings, W
    Knigge, H
    Montiel, J
    Fallois, J
    Agrawal, R
    Schramm, T
    Graf, C
    Giannetti, BM
    Bjarnason-Wehrens, B
    Prinz, U
    Rost, RE
    JOURNAL OF HUMAN HYPERTENSION, 2001, 15 (10) : 715 - 721
  • [37] ACUTE HEMODYNAMIC-EFFECTS OF CARVEDILOL (BM 14190), A NEW COMBINED BETA-ADRENOCEPTOR BLOCKER AND PRECAPILLARY VASODILATING AGENT, IN HYPERTENSIVE PATIENTS
    EGGERTSEN, R
    ANDREN, L
    SIVERTSSON, R
    HANSSON, L
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 27 (01) : 19 - 22
  • [38] Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension
    HG Predel
    W Mainka
    W Schillings
    H Knigge
    J Montiel
    Jv. Fallois
    R Agrawal
    T Schramm
    C Graf
    BM Giannetti
    B Bjarnason-Wehrens
    U Prinz
    RE Rost
    Journal of Human Hypertension, 2001, 15 : 715 - 721
  • [39] FELODIPINE IN COMBINATION WITH A BETA-BLOCKER AND A DIURETIC IN CHRONIC TREATMENT OF PATIENTS WITH REFRACTORY PRIMARY HYPERTENSION
    ANDERSSON, OK
    HEDNER, T
    GRANERUS, G
    DRUGS, 1987, 34 : 156 - 160
  • [40] Carvedilol, a new non-selective beta-blocker with intrinsic anti alpha adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis
    Banares, R
    GarciaPagan, JC
    Piqueras, B
    Casado, M
    Moitinho, E
    deDiego, A
    Escorsell, A
    Bandi, J
    Cos, E
    Bosch, J
    HEPATOLOGY, 1997, 26 (04) : 17 - 17
12345